Turning Routine Data to Predictive Care: Dr. Navdeep Tangri on CKD Risk Stratification using Algorithms
What drove the development of the Kidney Failure Risk Equation (KFRE), and how does it address the current unmet needs in CKD, specifically within the broader Cardiovascular-kidney-metabolic (CKM) context? Kidney disease is a...
Related Links
- NT-proBNP for Cardiovascular Risk Stratification in T2DM: From Evidence to Clinical Practice
- Perioperative Myocardial Injury (PMI): How to Build and Implement a Successful Multidisciplinary Team Protocol
- Beyond HbA1C: Overcoming Challenges in Insulin-Treated Type 2 Diabetes
- APSC Consensus Statement on the Management of Worsening Heart Failure
- Navigating Cardiotoxicity: A Practical Guide to Cardiac Biomarkers during Chemotherapy
- Continuous Glucose Monitoring with AI-enabled Predictive Algorithms for Diabetes Care: Expert Views from Hong Kong
- ACC 2025 Spotlight: DROP-Asian ACS Interim Analysis Highlights Regional Gains in NSTEMI Care
- Empowering the Everyday: AI-enabled CGM Is the Next Leap in Diabetes Care
- Lipoprotein(a) in clinical practice
- STRONG-HF Japan Study
- Innovative Strategies to Optimise Heart Failure GDMT at Prince Wales Hospital’s Heart Failure Clinic
- STRONG-HF Recommended in Updated China National Heart Failure Guideline 2023
- Rapid Titration (RaT) Pathway For Optimising Heart Failure GDMT with comprising several hospitals in Northland
- Reducing Mortality and Readmission with HF Multidisciplinary Model of Care
- Culturally Sensitive Diabetes Care
- What Causes Falsely High & Low HbA1c Reading?
- Menopause and Diabetes
- Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP
- Value of biomarker in HFpEF Diagnosis
- Sex-specific Differences in Heart Failure
- Management of CVD in Patients with Diabetes
- Heart Failure Care Beyond City Limits: Insights from a Cardiologist
- Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
- When every minute counts: A deep dive into IJN Malaysia’s quest for rapid triage for chest pain patients in the ED
- Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?
- Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
- Perioperative myocardial injury (PMI) management: Challenges and feasibility of active screening in non-cardiac surgeries
- Heart Failure Management in India – Overcoming Present Challenges
- Rational use of troponin and optimal management of cardiovascular diseases</strong>
- The evidence for 0/1-hour algorithm for Asia? DROP-Asian ACS Study
- Process Optimization for Emergency hs-TnT Detection
- Clinical Application NT-proBNP in CKD (Chronic Kidney Diseases) Patients with Cardiovascular Diseases
- High Sensitivity Troponin vs Conventional Troponin: An Expert View
- The rationale for the use of hs-cTn in the optimal management of ACS
- STROKESTOP II Study: Precision risk screening for atrial fibrillation in elderly
- Atrial Fibrillation in Elderly: Screening tools and role of NT-proBNP
- Advantages of early NT-proBNP testing in patients suspected with heart failure
- NT-proBNP: Increasing Clinical Confidence in Heart Failure Management
- What is the Peptide for Life initiative?
- Heart Failure in Asia – Present Challenges and Future Strategies
- Perioperative Myocardial Infarction in Non-Cardiac Surgery – Why Measuring Troponin is Important?
- Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus
- CANVAS (CANagliflozin cardioVascular Assessment Study): NT-proBNP and CVD risk reduction
- What should we take note of when using hs-TnT for CKD patient?
- Clinical Relevance – High-Sensitivity Troponin Results Influenced by Age
- Clinical Relevance of hs-TnT gender specific cut-offs
- Recommended Steps to Implement 0h/1h Algorithm in Asia
- Benefits of 0h/1h Algorithm in a Thai Institution
- Benefits of 0h/1h Algorithm to Patients in Asia
- How will NT-proBNP testing evolve in the future?
- Is NT-proBNP validated for different population groups?
- Reference ranges for NT-proBNP & hs-TnT in Asian populations
- Benefits of the 0h/1h algorithm in a Japanese institution
- Patient Case Studies Using 0h/1h Algorithm
- BNP vs NT-proBNP: An Expert View
- Impact of ARNi Therapy on Natriuretic Peptide Use
- How to Use NT-proBNP for Prognosis and Monitoring?
- What Should Hospitals Consider when Implementing Rapid Algorithm?
- TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test
- Benefits of hs-Tn 0h/1h Algorithm in ED & Hospital
- TRAPID-AMI Study: hs-TnT for Rapid Rule In/ Out of AMI
- Benefits of hs-Tn 0h/1h Algorithm to Chest Pain Patients
- How NT-proBNP Made a Difference: Dr Januzzi’s Patient Story
- Impact of High-Sensitivity Cardiac Troponin (hs-Tn) on Further Cardiac Testing in Suspected AMI Patients
- Advantages of Switching from Conventional to High-Sensitivity Troponin
- How hs-TnT Made a Difference – Dr Twerenbold’s Story
- How NT-proBNP Made a Difference: Dr Richards’ Patient Story
- Natriuretic Peptides in the Latest ESC & AHA HF Guidelines
- Role of Natriuretic Peptides in Patients with Dypsnea